Global firm buys Greenville drug manufacturer for $475M


A $4 billion life sciences company is acquiring a contract development and manufacturing organization in Greenville for $475 million.

Previous Here's a deeper dive into UAB's second-highest funded research project
Next Letter to the editor: Florida lawmakers need to take steps to stop prescription drug fraud